Efficacy of Olmesartan Medoxomil and Hydrochlorothiazide Fixed-Dose Combination Therapy in Patients Aged 65 Years and Older with Stage 1 and 2 Hypertension or Isolated Systolic Hypertension

2012 ◽  
Vol 12 (5) ◽  
pp. 325-333 ◽  
Author(s):  
F. Wilford Germino ◽  
Joel M. Neutel ◽  
Robert Dubiel ◽  
Jen-Fue Maa ◽  
Kathleen J. Chavanu
Keyword(s):  
Combination Therapy ◽  
Systolic Hypertension ◽  
Olmesartan Medoxomil ◽  
Fixed Dose Combination ◽  
Fixed Dose ◽  
Isolated Systolic Hypertension ◽  
Dose Combination ◽  
Stage 1

scholarly journals DIURETIC-BASED COMBINATION THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION: RESULTS OF THE RUSSIAN TRUST STUDY

2013 ◽  
Vol 12 (4) ◽  
pp. 62-66
Author(s):  
N. E. Gavrilova ◽  
R. G. Oganov
Keyword(s):  
Combination Therapy ◽  
Arterial Hypertension ◽  
Clinical Diagnosis ◽  
Modern Medicine ◽  
Fixed Dose Combination ◽  
Fixed Dose ◽  
High Prevalence ◽  
Dose Combination ◽  
Stage 1

Arterial hypertension (AH) is one of the most important problems of the modern medicine, due to its exceptionally high prevalence. This study focused on effectiveness and safety of the diuretic-based combination therapy among patients aged >18 years (1476 men and 2989 women) with a clinical diagnosis of Stage 1–3 AH. All patients received fixed-dose combination therapy with atenolol and chlorthalidone. The findings from the TRUST study have confirmed safety and effectiveness of the fixed-dose combination of atenolol and chlorthalidone. 

Fixed Dose Combination Therapy

1997 ◽  
Vol 90 (Supplement) ◽  
pp. 10-11
Author(s):  
William J. Elliott
Keyword(s):  
Combination Therapy ◽  
Fixed Dose Combination ◽  
Fixed Dose ◽  
Dose Combination
Sign in / Sign up

Export Citation Format

Share Document